AndrewSharabiMD
Radiation Oncology • La Jolla, CAAssociate Professor and Director of the Center for Precision Radiation Medicine
Dr. Sharabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
La Jolla, CA 92093
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2011 - 2015
Methodist Hospital (Houston)Internship, Transitional Year, 2010 - 2011
Baylor College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation Start of enrollment: 2015 Jan 07
- Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease Start of enrollment: 2016 May 03
- Stereotactic Body Radiation Therapy (SBRT) Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2017 Oct 26
Publications & Presentations
PubMed
- 40 citationsRole of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer PatientsSangwoo S. Kim, Whitney Sumner, Sayuri Miyauchi, Ezra E.W. Cohen, Joseph A. Califano
Clinical Cancer Research. 2021-07-06 - 34 citationsA data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patientsScott P. Robertson, Harry Quon, Ana P. Kiess, Joseph Moore, Wuyang Yang
Medical Physics. 2015-07-01 - 282 citationsKisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts.Martin Bilban, Nassim Ghaffari-Tabrizi, Edith Hintermann, Sandra Bauer, Sylvia Molzer
Journal of Cell Science. 2004-03-15
Press Mentions
News & PublicationsMay 1st, 2024- Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022
- Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
